-
Mashup Score: 0
Journal List Blood Cancer J v.11(3); 2021 Mar PMC7925672 Blood Cancer J. 2021 Mar; 11(3): 47. Paul J….
Source: PubMed Central (PMC)Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 22Biliary Obstruction Due to IgG4-Related Disease - 2 year(s) ago
A man in his sixth decade of life with a history of myasthenia gravis and antiphospholipid syndrome complicated by embolic strokes presented for evaluation of progressive jaundice and pruritus. Laboratory evaluation revealed marked hyperbilirubinemia and elevated lipase. Computed tomography imaging revealed a pancreatic head masslike lesion with a peripancreatic low-attenuation rim and dilation…
Source: Mayo Clinic ProceedingsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1IgG4-related orbital inflammation presenting as bilateral proptosis in a child - Eye - 2 year(s) ago
Eye – IgG4-related orbital inflammation presenting as bilateral proptosis in a child
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Emerging therapy options for IgG4-related disease - 2 year(s) ago
Awareness of IgG4-related disease (IgG4-RD) is increasing worldwide and specialists are now familiar with most of its clinical manifestations and mimickers. IgG4-RD promptly responds to glucocortic…
Source: Taylor & FrancisCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 12Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist - Nature Reviews Rheumatology - 2 year(s) ago
Awareness of IgG4-related disease, which shares many clinical, and potentially pathogenetic, similarities with certain rheumatic disorders, is increasing worldwide. This Review provides an overview of this disease entity, with particular focus on pathogenesis, clinical features, diagnosis and treatment, for the benefit of rheumatologists, who are increasingly likely to be involved in the…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6CAP Annual Meeting Agenda - CAP Annual Meeting - 2 year(s) ago
CAP Annual Meeting Agenda
Source: CAP Annual MeetingCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Autoimmune pancreatitis type 1 - 2 year(s) ago
Pancreas – Autoimmune pancreatitis type 1
Source: www.pathologyoutlines.comCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Recent studies in chronic myelomonocytic leukemia (CMML) involving clonal dendritic cell (DC) aggregates and association with systemic immune dysregulation have highlighted novel and potentially ta…
Source: Taylor & FrancisCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia - Leukemia - 2 year(s) ago
Islands of CD123high cells have been commonly described in the bone marrow of patients with chronic myelomonocytic leukemia (CMML). Using a multiparameter flow cytometry assay, we detected an excess of CD123+ mononucleated cells that are lineage-negative, CD45+, CD11c−, CD33−, HLA-DR+, BDCA-2+, BDCA-4+ in the bone marrow of 32/159 (20%) patients. Conventional and electron microscopy, flow…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
1️⃣Don’t mistake MPDCP w/ #BPDCN (your 👀+🔬= your best tool 2️⃣Mention MPDCP in your #pathology report! they have prognostic significance & associated w/ ⬇️ AML-free survival in #CMML shown by Dr. Lucas @MrinalPatnaik & Solary et al https://t.co/hZmmNLvWlF @LeukemiaJnl #WHOHEME https://t.co/o3c2fYKrfU
-
MPDCP are #Clonal pDC proliferations (neoplastic) & commonly w/ same mutations as the myeloid neoplasm they R ass. w/ (CMML: RAS pathway; AML: RUNX1) This beautiful Fig frm paper by Drs. Lucas @MrinalPatnaik ,Solary & et al. in @LeukemiaJnl https://t.co/hZmmNLvWlF #WHOHEME 3/ https://t.co/4lMENIGSlq
-
For refractory T-PLL there R no good options Retreat w/ alemtuzumab Can do alemtuzumab +pentostatin There is enthusiasm for #venetoclax (case reports and ongoing trials) https://t.co/wXwubnR8I9 @Bloodcancerjnl https://t.co/ZkmoxCTlFE @BloodJournal #WHOHEME